H2O Innovation has announced that its Water Technologies & Services (WTS) business line has recently been awarded three new water and wastewater treatment projects. These new contracts, with a total value of $7.9 M, bring the WTS backlog to $40.4 M.
The first project awarded to the Corporation involves the replacement of a municipal drinking water system that uses ultrafiltration (UF) in the city of Georgetown, Texas. The pilot project was successfully completed last winter, which positioned H2O Innovation to obtain the contract for the 3.6 MGD (13,627 m3/d) system thereafter. The initial system, which had been supplied by another manufacturer, lacked the flexibility that the city required in terms of membrane module replacement. H2O Innovation’s open-platform FiberFlexTM technology secured the Corporation the opportunity to carry out the project.
The second project is a double-pass reverse osmosis (RO) system to supply boiler make-up water to an industrial customer located in Wisconsin. The Corporation won this contract due to its ability to deliver the installation within a very tight schedule.
Finally, the last project awarded to H2O Innovation consists of a membrane bioreactor (MBR) system with a capacity of 276,000 GPD (1,045 m3/d) for an industrial client in Texas.
“These projects demonstrate our focus on the objectives outlined in our Strategic Plan, as we grow with a great diversification of high-quality municipal and industrial projects. They allow the WTS team to employ our engineering expertise and our unique designs, such as the FiberFlexTM flexible approach, and to deliver complete solutions to our customers for all kinds of applications (wastewater, water reuse, etc.). The team has really transformed over the past few years, which has led to these recent successes,” stated Gregory Madden, Chief Strategy Officer of H2O Innovation.
Prospective disclosures
Certain statements set forth in this press release regarding the operations and the activities of H2O Innovation as well as other communications by the Corporation to the public that describe more generally management objectives, projections, estimates, expectations or forecasts may constitute forward-looking statements within the meaning of securities legislation. Forward-looking statements concern analysis and other information based on forecast future results, performance and achievements and the estimate of amounts that cannot yet be determined. Those forward-looking statements, based on the current expectations of management, involve a number of risks and uncertainties, known and unknown, which may result in actual and future results, performance, and achievements of the Corporation to be materially different than the said forward-looking statements, such as the Corporation’s ability to execute, complete or deliver these projects, in a timely manner and without additional costs, mostly due to the challenges resulting from the global supply chain and the Covid-19 pandemic. Information about the risk factors to which the Corporation is exposed is provided in the Annual Information Form dated September 27, 2021 available on SEDAR (www.sedar.com).
